Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2011 R21 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
2018 R33 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer Complete
1999 R43 PAR-98-066 MILLER, JEFFREY E. IVS TECHNOLOGIES, LLC NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS Complete
2001 R43 PAR-99-101 SHEN, SHANXIANG PROTIVERIS, INC. MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING Complete
2004 R43 PAR-01-105 BECKER, CHRISTOPHER H SURROMED, INC. DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME Complete
2007 R33 RFA-CA-07-002 MOORE, PATRICK S. UNIVERSITY OF PITTSBURGH AT PITTSBURGH EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES Complete
2010 R21 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2014 R33 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2017 R33 RFA-CA-16-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Droplet microfluidic technology for single cell cancer genomics Complete
2001 R33 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2007 R21 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2009 R33 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R41 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2002 R43 PAR-01-105 FENG, LI ECHELON BIOSCIENCES, INC. LIPID MICROARRAYS Complete
2006 R21 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2016 R21 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2016 R21 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA Complete
2019 R33 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Complete
2000 R21 PAR-99-100 SUTHERLAND, JOHN CLARK BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB DNA DAMAGE QUANTITATION BY SINGLE MOLECULE LASER SIZING Complete
2002 R21 PAR-99-100 SWANSON, BASIL I. UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF CANCER Complete
2005 R21 RFA-CA-05-003 KANDEL, EUGENE S CLEVELAND CLINIC LERNER COL/MED-CWRU REVERSIBLE PROMOTER-INSERTION FOR IN VIVO STUDIES OF MELANOMA Complete
2008 R21 RFA-CA-07-035 BARBAS, CARLOS F SCRIPPS RESEARCH INSTITUTE ZINC FINGER RECOMBINASES FOR ENDOGENOUS GENOME TAILORING Complete
2011 R21 RFA-CA-10-005 SANTANGELO, PHILIP J GEORGIA INSTITUTE OF TECHNOLOGY CHARACTERIZING GENE REGULATION WITH SINGLE MOLECULE SENSITIVE PROBES Complete
2015 R21 RFA-CA-14-005 SOHN, LYDIA L UNIVERSITY OF CALIFORNIA BERKELEY ISOLATING CIRCULATING TUMOR CELLS Complete
2018 R33 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods Complete
1999 R43 PAR-98-066 NERI, BRUCE P THIRD WAVE TECHNOLOGIES, INC. SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION Complete
2001 R43 PAR-99-101 WANG, PENCHENG CALIBRANT BIOSYSTEMS, INC. 2-D MICROFLUIDIC GENE SCANNER Complete
2004 R43 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2007 R33 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2010 R21 RFA-CA-09-008 JI, HANLEE P STANFORD UNIVERSITY MUTATION ANALYSIS OF PARAFFIN-EMBEDDED TUMORS WITH NEXT GENERATION SEQUENCING Complete
2014 R33 RFA-CA-13-002 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2017 R33 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells Complete
2021 R21 CA20-017 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES Lab on a particle technology for functional screening of therapeutic cells Complete
2001 R33 PAR-98-067 MEYER, TOBIAS STANFORD UNIVERSITY CELL ARRAYS FOR SCREENING SIGNAL TRANSDUCTION PROCESSES Complete
2003 R33 PAR-01-106 LIZARDI, PAUL M. YALE UNIVERSITY GENETIC ANALYSIS OF AMPLIFIED GENOMIC DNA ARCHIVES Complete
2007 R21 RFA-CA-07-001 STEINMAN, RICHARD A UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NUCLEOSOMAL BIOSENSOR FOR IDENTIFICATION AND ISOLATION OF NUCLEAR HORMONE RECEP Complete
2009 R33 RFA-CA-08-008 ELLEDGE, STEPHEN J BRIGHAM AND WOMEN'S HOSPITAL A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY Complete
2013 R33 RFA-CA-12-003 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Complete
2000 R41 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2002 R43 PAR-01-105 ISRAEL, BARBARA A. PLATYPUS TECHNOLOGIES, LLC OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS Complete
2006 R21 RFA-CA-06-003 SCHMITTGEN, THOMAS D OHIO STATE UNIVERSITY REAL-TIME PCR EXPRESSION PROFILING OF MICRORNA Complete
2009 R21 RFA-CA-08-006 HELD, JASON M. BUCK INSTITUTE FOR RESEARCH ON AGING OXMRM: A TECHNIQUE TO QUANTIFY OXIDATION OF ENDOGENOUS REDOX-SENSITIVE CYSTEINES Complete

Pages